These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28754688)

  • 1. TRIM65 triggers β-catenin signaling via ubiquitylation of Axin1 to promote hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Zhang CZ
    J Cell Sci; 2017 Sep; 130(18):3108-3115. PubMed ID: 28754688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation.
    Wei WS; Chen X; Guo LY; Li XD; Deng MH; Yuan GJ; He LY; Li YH; Zhang ZL; Jiang LJ; Chen RX; Ma XD; Wei S; Ma NF; Liu ZW; Luo JH; Zhou FJ; Xie D
    Cancer Lett; 2018 Oct; 435():10-22. PubMed ID: 30075204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
    Yang YF; Pan YH; Cao Y; Fu J; Yang X; Zhang MF; Tian QH
    Oncotarget; 2017 Jul; 8(29):47195-47205. PubMed ID: 28525379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM11 promotes lymphomas by activating the β-catenin signaling and Axin1 ubiquitination degradation.
    Hou Y; Ding M; Wang C; Yang X; Ye T; Yu H
    Exp Cell Res; 2020 Feb; 387(2):111750. PubMed ID: 31786079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt/β-catenin pathway via ubiquitination of Axin1.
    Shen J; Yu Z; Li N
    Biochem Biophys Res Commun; 2018 Sep; 503(2):991-997. PubMed ID: 29932918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K-AKT-β-catenin pathways.
    Xie L; Dai H; Li M; Yang W; Yu G; Wang X; Wang P; Liu W; Hu X; Zhao M
    J Cell Mol Med; 2019 May; 23(5):3386-3401. PubMed ID: 30793486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripartite motif 8 promotes the progression of hepatocellular carcinoma via mediating ubiquitination of HNF1α.
    Peng Y; Qian H; Xu WP; Xiao MC; Ding CH; Liu F; Hong HY; Liu SQ; Zhang X; Xie WF
    Cell Death Dis; 2024 Jun; 15(6):416. PubMed ID: 38879600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3.
    Zhang Q; Li Y; Zhu Q; Xie T; Xiao Y; Zhang F; Li N; Deng K; Xin H; Huang X
    Cell Death Dis; 2024 May; 15(5):355. PubMed ID: 38777825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIM32 triggers β-catenin signaling through ubiquitylation of AXIN1 to promote inflammatory factor-induced apoptosis of rat nucleus pulposus cells.
    Chen F; Guo Q; Chen Q; Han Z; Zhou X; Wu L; Guo X; Ni B; Yang J
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C695-C703. PubMed ID: 31967859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM65 knockout inhibits the development of HCC by polarization tumor-associated macrophages towards M1 phenotype via JAK1/STAT1 signaling pathway.
    Jiang M; Wang D; Su N; Lou W; Chen Y; Yang H; Chen C; Xi F; Chen Y; Deng L; Tang X
    Int Immunopharmacol; 2024 Feb; 128():111494. PubMed ID: 38218012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE3C promotes proliferation and inhibits apoptosis by activating the β-catenin signaling via degradation of AXIN1 in gastric cancer.
    Zhang Y; Xu J; Fu H; Wei Z; Yang D; Yan R
    Carcinogenesis; 2021 Feb; 42(2):285-293. PubMed ID: 32930707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin.
    Yuan K; Xie K; Lan T; Xu L; Chen X; Li X; Liao M; Li J; Huang J; Zeng Y; Wu H
    Cell Death Differ; 2020 Apr; 27(4):1355-1368. PubMed ID: 31570854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
    Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
    Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway.
    Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J
    Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.